Man Group’s Corbus Pharmaceuticals CRBP Stock Holding History

Man Group’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,673	Closed	-$693K	–	2059
2024 Q1	$693K	Buy	+17,673	New	+$436K	﹤0.01%	1671

Other funds holding CRBP

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Man Group's CRBP Position: Q2 2024 in Review

Man Group sold out of Corbus Pharmaceuticals (CRBP) in Q2 2024, closing a stake of 17,673 shares — an estimated $693K sold.

Man Group first reported a position in CRBP in Q1 2024 and held it in 1 quarter. The position peaked at $693K in Q1 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2024.

Man Group reported no remaining Corbus Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Man Group sold 17,673 Corbus Pharmaceuticals shares in Q2 2024, an estimated $693K.
Man Group first reported a position in Corbus Pharmaceuticals in Q1 2024 and held it in 1 quarter.
Man Group's Corbus Pharmaceuticals position peaked at $693K in Q1 2024.
107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2024.

Based on Man Group's 13F filing for Q2 2024, filed 14 Aug 2024.